Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) Invested Capital (2020 - 2025)

Bio Essence has reported Invested Capital over the past 6 years, most recently at -$2.1 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 30.18% year-over-year to -$2.1 million; the TTM value through Dec 2025 reached -$2.1 million, up 30.18%, while the annual FY2025 figure was -$2.1 million, 30.18% up from the prior year.
  • Invested Capital for Q4 2025 was -$2.1 million at Bio Essence, up from -$3.1 million in the prior quarter.
  • Over five years, Invested Capital peaked at $883.7 million in Q3 2021 and troughed at -$3.4 million in Q1 2023.
  • A 5-year average of $42.0 million and a median of -$2.5 million in 2021 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: surged 52337.3% in 2021 and later plummeted 1892.09% in 2022.
  • Year by year, Invested Capital stood at -$2.4 million in 2021, then crashed by 33.62% to -$3.2 million in 2022, then skyrocketed by 48.71% to -$1.7 million in 2023, then crashed by 79.27% to -$3.0 million in 2024, then skyrocketed by 30.18% to -$2.1 million in 2025.
  • Business Quant data shows Invested Capital for BIOE at -$2.1 million in Q4 2025, -$3.1 million in Q3 2025, and -$3.1 million in Q2 2025.